Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00116558 · ClinicalTrials.gov registry record · NA
Early Treatment of Amyotrophic Lateral Sclerosis (ALS) With Nutrition and Non-Invasive Positive Pressure Ventilation
A NA study of Amyotrophic Lateral Sclerosis, sponsored by Edward Kasaraskis.
- Completed
- Registry status
- NA
- Development phase
- 153
- Enrollment target
- 12
- Study locations
NCT00116558: Completed NA study of Amyotrophic Lateral Sclerosis, sponsored by Edward Kasaraskis.
NCT00116558 is a NA study of Amyotrophic Lateral Sclerosis that has completed, run by Edward Kasaraskis. The registered enrollment target is 153 participants, below the 896-participant average among 102 other Amyotrophic Lateral Sclerosis trials with a reported enrollment target (83% lower). The trial reports 12 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00116558, a NA study of Amyotrophic Lateral Sclerosis, has completed, sponsored by Edward Kasaraskis.
- COMPLETED
- Registry status
- NA
- Development phase
- 153 participants
- Enrollment target
- 12
- Study locations
Study Summary
The purposes of the study are to determine the energy balance and evaluate the nutritional status of patients with ALS, and to investigate the use of NIPPV as respiratory support to treat patients with ALS.
Primary Outcome
Percentage of patients attempting to use NIPPV therapy within six weeks of initial offer.
Conditions Studied
Interventions
- DEVICE Early NIPPV
- DEVICE Standard NIPPV
Study Locations (12)
New York
- Beth Israel - New York
- Columbia University - New York
- SUNY - Syracuse
Pennsylvania
- Pennsylvania State University - Hershey
- Drexel University - Philadelphia
Colorado
- University of Colorado - Denver
Florida
- University of Miami - Miami
Kentucky
- University of Kentucky - Lexington
Michigan
- Henry Ford Hospital - Detroit
Texas
- University of Texas-San Antonio - San Antonio
Utah
- University of Utah - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 153 participants |
| Start Date | 2004-08-01 |
| Est. Completion | 2012-01 |
| Phase | NA |
What the finished NCT00116558 record still lists
NCT00116558 is an interventional study that assigns participants to a tested intervention. The registered 153 participants enrollment target is mid-sized for trials with a published cap, below the 896-participant average among 102 other Amyotrophic Lateral Sclerosis trials with a reported enrollment target (83% lower).
The record links to 1 condition, with Amyotrophic Lateral Sclerosis appearing as the primary indexed condition, and to 2 interventions - of which Early NIPPV is the first listed.
NCT00116558 lists 12 locations in 9 states (New York, Pennsylvania, Colorado).
Frequently Asked Questions
What is clinical trial NCT00116558 about?
NCT00116558 is a clinical study titled "Early Treatment of Amyotrophic Lateral Sclerosis (ALS) With Nutrition and Non-Invasive Positive Pressure Ventilation". The purposes of the study are to determine the energy balance and evaluate the nutritional status of patients with ALS, and to investigate the use of NIPPV as respiratory support to treat patients with ALS.
What is the current status of trial NCT00116558?
This trial is currently completed. It is a NA study. The enrollment target is 153 participants. The study started on 2004-08-01. Estimated completion is 2012-01.
What conditions does trial NCT00116558 study?
This clinical trial studies the following conditions: Amyotrophic Lateral Sclerosis.
What interventions are being tested in trial NCT00116558?
The interventions under investigation include: Early NIPPV (DEVICE), Standard NIPPV (DEVICE).
Who is sponsoring clinical trial NCT00116558?
This trial is sponsored by Edward Kasaraskis, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00116558 being conducted?
This trial has 12 study locations across Colorado, Florida, Kentucky, Michigan, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Amyotrophic Lateral Sclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00116558's enrollment target sits among peer trials
153 35th of 102 higher than 68 of 102 other Amyotrophic Lateral Sclerosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Amyotrophic Lateral Sclerosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)
RECRUITING · NA
-
Assessing Perceptual Effects of Interactive Tasks
RECRUITING · NA
-
Spinal Cord Associative Plasticity for ALS
RECRUITING · NA
-
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
RECRUITING · NA
-
Oral Intake of Enteral Nutrition Formula Preceding Placement and Feeding Via GTube and Its Impact on Formula Intolerance in pALS
RECRUITING · NA
-
Precise Robotically IMplanted Brain-Computer InterfacE
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05283265 · 153 participants · NA
Neurophysiological Mechanisms of Language Comprehension
- NCT05554393 · 153 participants · Phase 2
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
- NCT05584501 · 153 participants · NA
ETE Interventions in the Dental Setting
- NCT05714839 · 153 participants · Phase 1
A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI